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Direct Mechanical Ventricular Actuation (DMVA) is a non-
blood contacting cardiac assist device that augments 
ventricular function. The purpose of this study was to 
determine if a volume-regulated “hand pump” drive system 
and a pressure-regulated “switch tank” drive system provide 
equivalent levels of cardiac support. Canine (n=2) and 
swine (n=4) were instrumented for hemodynamic monitoring 
and intravascular echocardiography. DMVA support was 
assessed during both severe heart failure and fibrillation. 
Pump function was evaluated using hemodynamic measures to 
calculate stroke work. Myocardial function was assessed 
using echocardiographic speckle tracking to quantify strain 
rate. Results were compared between groups using paired t-
tests. There were no significant differences in either pump 
function or myocardial strain rates between the hand pump 
versus switch tank during support of either the failing or 
fibrillating heart. These results suggest functional 
equivalency between the two drive system mechanisms that 
supports development of an automated volume-regulated 
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system, with its corresponding benefits in reduced size, 
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There is currently an unmet need in medicine to provide 
rapid and effective circulatory support for victims of 
acute cardiac failure or arrest. Pharmacological management 
of heart failure with inotropes can augment myocardial 
function. However, these drugs also exacerbate the already 
increased physiologic demands of heart. Judicious 
administration of volume and/or vasodilators can improve 
cardiac dynamics through alterations in preload and 
afterload, respectively. When these efforts fail, acute 
failure enters a downward cycle where the heart 
progressively deteriorates as failure becomes increasingly 
severe.  
 
In such situations it becomes necessary to directly 
supplant the failing heart’s inadequate pumping ability 
with mechanical circulatory support (MCS). Clinically 
available MCS devices consist of blood pumps. The use of 
these devices in combination with an oxygenator (i.e. 
cardiopulmonary bypass) allows support of the entire 
circulation during open heart surgery or for short-term 
resuscitative support.  A wide variety of MCS devices have 
also been developed to assist the failing heart and 
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typically rely on the native lung function for blood 
oxygenation.  All these devices have common drawbacks (e.g. 
blood contact, technically demanding installation) that 
limit their feasibility for resuscitative support of the 
acutely failing or arrested heart.  
 
Resuscitative cardiac support therapies are predominantly 
limited to those defined in the Advanced Cardiac Life 
Support algorithms developed by the American Heart 
Association.
3
 These algorithms primarily make use of chest 
compressions, defibrillation, and drug interventions to 
provide cardiac support. Unfortunately, despite increased 
awareness of cardiopulmonary resuscitation techniques among 
the public and an emphasis on timely defibrillation, most 
patients who suffer cardiac arrest cannot be successfully 













DIRECT MECHANICAL VENTRICULAR ACTUATION 
 
Direct Mechanical Ventricular Actuation (DMVA) is a 
MCS device consisting of a polymer cup that augments both 
systolic and diastolic ventricular function (Figure 1).
11
 
The DMVA cup is composed of a hard outer shell enclosing a 
flexible polymer diaphragm. The ventricles are positioned 
inside the cup so the epicardial surface contacts the inner 
membrane (Figure 2). The space between the outer shell and 
inner diaphragm is pneumatically isolated save for a 
connection with a pulsatile driving mechanism. Ventricular 
actuation is achieved by cyclic introduction and removal of 
air into this space, which act to expand and retract the 
flexible diaphragm, respectively. These forces are 
translated to the surface of the ventricle after device 
attachment. Attachment is achieved by a continuous low 
vacuum delivered via an apical port on the cup. This vacuum 
both prevents expulsion of the heart during systolic 
compression and allows the diaphragm to adhere to the 
heart’s epicardial surface. Proper vacuum attachment is 
necessary for effective translation of diaphragm forces to 










Figure 1 – Representation of the DMVA support system during 
diastolic and systolic support. The DMVA system consists of 
the DMVA cup, a pulsatile driving mechanism, and a 












Figure 2 – Diagram showing the various features of the DMVA 
cup. The cup consists of a hard outer shell and a flexible 
inner diaphragm. The ventricles are positioned inside the 
cup so their epicardial surface is in contact with the 
inner diaphragm. The pulsatile drive system uses air to 
expand and retract the flexible diaphragm. A low continuous 
vacuum applied to heart apex facilitates a seal between the 
epicardium and diaphragm that allows for effective 
translation of diaphragm motions to the ventricles. 




DMVA has a inherent advantages when compared to other MCS 
devices that make DMVA better suited for cardiac 
resuscitation.
9
 Most clinical MCS devices are best 
characterized as blood pumps that reroute blood around the 
ventricles. These devices typically require anticoagulants 
to prevent thromboembolic complications from interactions 
with MCS surfaces. In contrast DMVA only contacts the 
heart’s surface, thereby eliminating this need. 
 
Installation of MCS devices is relatively time-consuming 
and technically-challenging, sometimes requiring hours and 
specialized surgeons. DMVA is simple to install, requiring 





The ability to provide rapid resuscitative circulatory 
support suggests DMVA would have a favorable impact on the 
time-sensitive nature of cerebral resuscitation. DMVA 
installation is dependent on gaining adequate exposure to 
the heart’s surface and thereby requires technically 
simpler surgical skills compared to other devices, which 






Additionally, there can be the need to install two typical 
MCS devices in tandem in order to provide biventricular 
support since many are univentricular devices. In contrast 
both ventricles are inserted into the DMVA cup, so support 
can benefit both the right and left ventricle, as is 
frequently necessary.  
 
Many newer MCS devices are continuous flow pumps that use 
an impeller to circulate blood throughout the body.
2
 These 
pumps are useful for their enhanced implantability and 
reduced power requirements, but sacrifice the enhanced 
perfusion provided by physiologic pulsatile flow. DMVA’s 
pulsatile blood flow and use of the ventricles in pumping 
promote a more physiologic level of perfusion.
16
   
 
DMVA should be distinguished from simple direct cardiac 
compression (DCC) devices, which only apply external 
compression forces to the surface of the heart.  A key 
weakness of DCC is the lack of diastolic assist and the 
subsequent limitations on diastolic filling incurred by 
only compressing the heart. This produces stroke volume 
insufficiencies and thereby limits the efficacy of such 
circulatory support modalities.
15
 In contrast DMVA augments 
both systolic and diastolic function.   
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DMVA DRIVE SYSTEMS 
 
Historically, positive and negative pressure tanks have 
been used to generate pulsatile flow for DMVA. In this type 
of system, known as the “switch tank”, the cup is actuated 
by rapidly alternating between these tanks. However, this 
pressure-regulated approach imposes restrictions in both 
mobility and compactness that limit use of the device to 
established medical centers.  Additionally, control of such 
devices has been imprecise and non-intuitive to unfamiliar 
users. Recent research in both small and large animal 
models has focused on volume-regulated systems using a 
hand-operated pneumatic piston known as the “hand pump” to 


















Figure 3 – (Left) Volume-Regulated (Hand Pump) and (Right) 
Pressure-Regulated (Switch Tank) drive systems 
demonstrating the means of inducing pneumatic compression 











Echocardiography (ECHO) has been a useful tool for 
evaluating myocardial function, generally defined by 
visually tracking ventricular wall motions. Strain and 
strain rate in particular have emerged as quantitative 
estimates of myocardial function and contractility.
20-22
 
Strain is the deformation of an object compared to its 
original length while strain rate is the rate at which that 
relative deformation occurs (Figure 4). Strain rate in 





To use strain and strain rate as useful parameters, 
however, there must be some way to track ventricular wall 
motions. The two primary methods of wall tracking are 
tissue Doppler imaging and speckle tracking.20 Tissue 
Doppler imaging makes use of ultrasound frequency shifts 
when reflecting off moving objects to measure instantaneous 
tissue velocity gradients in small myocardial segments 
(which can be converted to strain rate). However Doppler is 
highly angle-dependent (i.e. the beam must be parallel to 



















Figure 4 – Definition of Lagrangian strain (ε) as the 











Speckle tracking uses randomly distributed acoustic markers 
(speckles) to uniquely characterize a section of the 
ultrasound image.
19
 Speckles are caused by reflections from 
microscopic boundaries in the tissue being analyzed, 
meaning each tissue section presents a characteristic 
speckle pattern. Each speckle section can be followed over 
a number of consecutive frames (necessitating a 
sufficiently high frame rate) before tissue motion brings 
the speckle section out of frame. Frame-to-frame changes 
can be tracked by using sum of absolute difference 
algorithms. In addition to its angle-independent nature, 
speckle tracking only needs a single cardiac cycle and 
analysis can be performed offline using captured two-
dimensional images. Speckle tracking strains and strain 
rates have shown good correlation and agreement with 
sonomicrometry when measured under a variety of 
conditions.
20
   
 
Strain and strain rate can be measured along three heart 
axes: longitudinal, radial, and circumferential (Figure 5). 
Longitudinal strain measurements rely on a long-axis view 
of the heart while radial and circumferential strain 
measurements rely on a short-axis view. In this study, a 
13 
 
long-axis view was better obtainable due to positioning of 
the ultrasound transducer to avoid passing the beam through 
the air-filled portions of the DMVA cup. The myocardium is 
a complex network of overlying layers that contract, 
stretch, rotate, and twist in three dimensions, but 
longitudinal strain and strain rates (which play are large 
part in determining compression and relaxation of the 
ventricles assuming constant ventricular volumes) have been 
demonstrated as an accurate relative measure of myocardial 
function.
21




















Figure 5 – Diagram showing different axes of myocardial 
strain (L – Longitudinal, R – Radial, C – Circumferential) on 
the left ventricle. The longitudinal axis was used for 
strain analysis during this study because of its utility in 
characterizing myocardial strain and attainability because 
the beam does not have to pass through the air-filled 






The purpose of this study was to investigate whether there 
is functional equivalency between switch tank and hand pump 
driven DMVA support when applied to the severely failing or 




The Wright State University Lab Animal Care and Use 
Committee approved the experimental protocol, and all 
animals were treated in compliance with the Guide for the 
Care and Use of Laboratory Animals, published by the 





Large animal models, comprised of Yorkshire Swine (n = 4) 
and canine (n = 2) subjects, were studied. Subjects were 
pre-anesthesized with Telazol (6 mg/kg), Xylazine          
(3 mg/kg), and Atropine (0.02 mg/kg) followed by tracheal 
intubation and mechanical ventilation. Anesthesia was 
maintained with 1-2% isoflurane. Vascular access for drug 
infusion was achieved through bilateral femoral cutdowns.  
Phenylephrine was used to regulate subject arterial 
pressure. The subjects were instrumented for left 
ventricular, femoral artery, and central venous pressures. 
A 10-MHz Acuson AcuNav10F ultrasound catheter was 
positioned through the right jugular vein for intravascular 
imaging. Two-chamber, left heart long-axis ECHO video clips 
encompassing a couple heart cycles were obtained on the 
Acuson Sequoia C512 ECHO system.(Note: A summary of 
instrumentation is in Table 1). A median sternotomy and 
pericardiotomy were performed. An ultrasound flow probe was 
placed on the ascending aorta to measure cardiac output. 
Surface electrocardiogram, hemodynamics, pulse oximetry, 
end-tidal carbon dioxide, and rectal temperature were 




Both the hand pump and switch tank drive systems were 
instrumented to measure pulsatile and continuous vacuum 
pneumatic pressures and pulsatile flow. The displacement of 
the hand pump was measured using a string potentiometer. 






























































































Figure 6 – Schematic of experimental setup and data 
collection: intravascular echocardiography probe, aortic 
flowmeter, arterial pressure transducer, and pneumatic 
pressure transducers and flowmeter. The switch tank and 
hand pump drive systems were alternated to assess any 











After collection of post-sternotomy baseline data, a 9-volt 
battery was applied to the epicardial surface to induce 
ventricular fibrillation. Following a 5-minute fibrillation 
period, DMVA support was provided for 15 minutes. After 
this initial support period hearts were defibrillated. If 
defibrillation was unsuccessful, DMVA support would 
continue for another 15 minutes before another 
defibrillation attempt was made. However, if normal cardiac 
rhythm was restored, the current cardiac output was 
compared to baseline cardiac output to determine the level 
of failure. If severe failure was present (cardiac output ≤ 
60% baseline) after defibrillation, DMVA support was 
applied for 15 minutes. If not in severe failure the heart 
would remain unsupported for a 15 minute recovery period. 
After either completing a supported failure or recovery 
period, fibrillation was induced again to restart the cycle 
(see Figure 7). For each 15 minute period of support, the 
drive system was alternated between the switch tank and 
hand pump systems every 3 minutes.  This cycle was repeated 
over an experimental duration of 2 hours. Appropriate 
physiologic and drive parameters were collected through all 
the experimental states: (1) baseline, (2) unsupported 
21 
 
fibrillation, (3) unsupported severe heart failure, switch 
tank support during (5) fibrillation and (6) failure, hand 
pump support during (7) fibrillation and (8) failure, and 
(9) recovery. The maximum pressure and rate settings of the 
(automated) switch tank system were approximated by the 
experimenters operating the manual hand pump system via 





Stroke work (SW) (Equation 1), as a measure of pump 
function, was estimated from the product of mean arterial 
pressure (MAP) and stroke volume (SV) acquired via 
integration of aortic flow (i.e. cardiac output (CO)/heart 











































































Digitized intravascular two-chambered long-axis ECHO video 
clips of the left heart were interrogated to assess 
myocardial function.  Velocity vector imaging (VVI) 
software (Siemens Medical Solutions) was used to calculate 
longitudinal myocardial strain rates via speckle tracking.  
The endocardial border of a video clip was traced during 
end-diastole and played to ensure tracing fidelity to wall 
motions (Figure 8). The endocardial border was divided into 
six sections representing the basal, mid-wall, and apical 
regions of the septal and free-wall sides of the left 
ventricle, with each region represented by a strain rate 
waveform (Figure 9). Each waveform was characterized by a 
peak systolic and diastolic value. A systolic and diastolic 
average was computed for the six regions, defined in this 
study as global strain rate, to estimate myocardial 
function of the left ventricle.
18
 Paired t-tests were used 
to test for significant differences (p < 0.05) between 
























Figure 8 – This study used an intravascular 
echocardiography probe to capture left ventricular images.  
The above image is a characteristic view acquired with 
speckle tracking tracing along the endocardial border to 
compute tissue velocity, strain, and strain rate as 







Septum Free Wall 
RV = Right Ventricle 
LV = Left  Ventricle 






Figure 9 – Example VVI strain rate results after 
endocardial tracing. The heart was divided into six 
segments and the peak values in both systole and diastole 
were calculated. The averages of these six peaks (global 
peak strain rate) for systole and diastole were used an 








As a reminder, the main comparisons being made in this 
study are between the hand pump and switch tank in heart 
failure and the hand pump and switch tank in ventricular 
fibrillation. In this case, failure represents partial 
heart functionality while fibrillation represents 
negligible function (which is the reason for not including 
unsupported fibrillation is the results). Quantitatively, 
stroke work, representing overall pump function, and peak 
ECHO strain rates, representing myocardial function, were 
selected to demonstrate these comparisons. 
 
The stroke work (computed from pressures and flows in 
Figure 10) data in Figure 11 shows no significant 
difference (p > 0.05) between the two drive systems in 
either separate failure or fibrillation comparisons while 
significantly higher (p < 0.05) values were obtained during 










Figure 10 – Graph of representative arterial pressure 
(dashed line) and aortic flow (black line) waveforms. This 
data was used to compute the stroke work of the heart 








































Arterial Pressure (mm Hg)
Aortic Flow(L/min)
SW = Stroke Work, SV = Stroke Volume, MAP = Mean Arterial Pressure,  



























































Figure 11 – Mean heart stroke work estimates for 
unsupported and supported heart failure and supported 
fibrillation.  There was no significant difference between 
switch tank (black) and hand pump (white) support compared 
in either failure or fibrillation. There was a significant 
increase in stroke work during supported failure compared 
to unsupported failure (shaded). 
 
 
    
 
* 
*HF Support > HF Unsupported (p < 0.05); HF = Heart Failure, VF = Ventricular 




ECHO strain rate data shows similar trends to that of 
stroke work. In comparing the two drive systems in both 
failure (Figure 12) and fibrillation (Figure 13), no 
significant differences (p > 0.05) were found between the 
switch tank and hand pump.
17
 This strain rate data was 
further divided into systolic and diastolic measures, also 
displaying non-significance when compared between drive 
systems. Support during failure (Figure 12) produced 
significant increases (p < 0.05) in max strain rates 
























Figure 12 – Peak global strain rate magnitudes for systole 
and diastole in the failing heart during non-support, 
switch tank support, and hand pump support. There was no 
significant difference in peak global strain rates when 
comparing the two drive systems during either systole or 
diastole. There was a significant increase in peak global 
strain rate during supported failure compared to 



























ECHO Heart Failure Comparison
Peak Systolic SR (1/s)




*HF Support > HF Unsupported (p < 0.05); HF = Heart Failure, VF = Ventricular 










Figure 13 – Peak global strain rate magnitudes for systole 
and diastole during support of fibrillated hearts using the 
switch tank and hand pump drive systems. There was no 
significant difference in peak global strain rates when 
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ECHO Fibrillation Comparison 





ECHO interrogation has been a valuable tool that allows for 
a clinically-relevant assessment of device function. 
Traditionally, ECHO imaging has been used to visually 
evaluate the heart structure and calculate estimates of key 
cardiac parameters such as ejection fraction, stroke 
volume, cardiac output and stroke work. Speckle tracking 
has opened up a whole new level of analysis in that tissue 
function can be evaluated directly.  
 
The inclusion of both stoke work and ECHO strain rates was 
meant to create a bridge between traditional measures using 
pump function and cutting-edge measures using myocardial 
function. Pump function measurements are indicators of the 
heart’s ability to circulate blood while myocardial 
measurements reflect cardiac muscular function, which are 
thought to be a more direct measure of cardiac health. Both 
variables (stroke work and global max strain rate) 
demonstrated predicted significant increases in supported 
failure. This demonstrates the utility of DMVA for
33 
 
increasing circulatory function during heart failure (in 
line with previous work in small animal models). 
 
It is important to note that the max pressure and rate 
settings being the same do not necessarily guarantee that 
the waveforms have the same shape. The different mechanisms 
of pneumatic support may alter the pressure dP/dt profiles 
in a significant manner without creating a functional 
difference in cardiac support.     
 
The lack of difference between support provided by the two 
drive systems in either failure or fibrillation indicates a 
functional equivalency at approximately the same max 
pressure and rate settings. Given the advantages of a 
typical volume-regulated system (practical control features 
and compactness) it appears that an automated hand pump 
would provide the listed benefits without any significant 
performance degradation compared to the established switch 





This study suggests that there is no significant difference 
between DMVA support provided by an established pressure-
regulated switch tank and an experimental volume-regulated 
hand pump. Equivalency was established based on hemodynamic 
and cardiac wall motion comparison during support of severe 
failure and fibrillation using both drive systems. Given 
the lack of significant difference between the drive 
systems, the findings suggest that an automated drive 
system could be constructed that incorporates the hand pump 
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